ORPHAN DRUGS VERSUS ULTRA-ORPHAN DRUGS: PRICE COMPARISON IN ENGLAND

被引：0

作者：

Chachoua, L. ^{[1
]}

Hanna, E. ^{[2
]}

Zhou, J. ^{[3
]}

Dussart, C. ^{[4
]}

Toumi, M. ^{[3
]}

机构：

[1] Market Access Soc, Paris, France

[2] Creat Ceut, Paris, France

[3] Aix Marseille Univ, Marseille, France

[4] Lyon 1 Univ, Lyon, France

来源：

关键词：

D O I：

10.1016/j.jval.2018.07.822

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSY6

引用

页码：S107 / S107

页数：1

共 50 条

[31] THE ORPHAN DRUGS
KASILO, O
FIORICA, E
REGGI, V
TOGNONI, G
MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1986, 6 (03): : 295 - 300
[32] ORPHAN DRUGS
RHEIN, R
BRITISH MEDICAL JOURNAL, 1990, 301 (6745): : 198 - 199
[33] ORPHAN DRUGS
不详
SOUTH AFRICAN MEDICAL JOURNAL, 1983, 63 (24): : 914 - 914
[34] ORPHAN DRUGS
Fontanet Sacristan, Juan Manuel
Torrent-Farnell, Josep
ARBOR-CIENCIA PENSAMIENTO Y CULTURA, 2018, 194 (789)
[35] Orphan drugs
Novack, Gary D.
OCULAR SURFACE, 2008, 6 (01): : 52 - 55
[36] PREDICTING VALUE AND PRICE OF ORPHAN DRUGS: A COMPARISON ACROSS EUROPE AND THE US
Ganesh, S.
Anstee, K.
VALUE IN HEALTH, 2023, 26 (12) : S382 - S382
[37] CHANGES IN ULTRA-ORPHAN DRUG ASSESSMENTS IN POLAND
Vaithyanathan, G.
Dekkers, R.
van Engen, A.
VALUE IN HEALTH, 2018, 21 : S201 - S201
[38] HTA OUTCOMES FOR ORPHAN DRUGS IN ONCOLOGY: COMPARISON OF FRANCE, GERMANY AND ENGLAND
Jaroslawski, S.
Toumi, M.
Korchagina, D.
Auquier, P.
Dussart, C.
VALUE IN HEALTH, 2018, 21 : S111 - S111
[39] Orphan drugs and orphan tests in the USA
Thoene, JG
COMMUNITY GENETICS, 2004, 7 (04) : 169 - 172
[40] COMPARISON OF ORPHAN DRUGS PRICES: A EUROPEAN COMPARISON
Hanna, E.
Chachoua, L.
Achour, L.
Dabbous, M.
Toumi, M.
VALUE IN HEALTH, 2018, 21 : S86 - S86